The objective of this study was to determine the virological response and the possible
emergence of drug resistance at 1 and 2 years postpartum in HIV-positive pregnant women …

With antiretroviral therapy (ART) recommended by the World Health Organization (WHO) for
children aged< 2 years with human immunodeficiency virus (HIV) and continuing global …

Background Programs for the prevention of mother-to-child transmission (PMTCT) of human
immunodeficiency virus (HIV) have been scaled up in many low-and middle-income …

We conducted a retrospective cohort study in HIV-positive pregnant women in a tertiary care
infectious diseases clinic. From January 1999 to December 2004, 80 pregnant women had …

Access to combination antiretroviral treatment (ART) has improved greatly over recent years.
At the end of 2011, more than eight million HIV-infected people were receiving ART in low …

BACKGROUND: Antiretrovirals suppress HIV replication and prevent mother-to-child-
transmission of HIV (PMTCT). Resistance to antiretrovirals may reduce the efficacy of …

Pediatric human immunodeficiency virus (HIV) care in resource-limited settings remains a
major challenge to achieving global HIV treatment and virologic suppression targets, in part …

Antiretroviral therapy (ART) is recommended for all people infected with human
immunodeficiency virus (HIV). The importance of wide population coverage and effective …

The rapid scale-up of highly active antiretroviral therapy (HAART) and use of single dose
Nevirapine (SD NVP) for prevention of mother-to-child transmission (pMTCT) have raised …

In the absence of interventions, 30–45% of exposed infants acquire human
immunodeficiency virus type 1 (HIV‐1) through mother‐to‐child transmission. It remains …